Stock listing
gettex:1K9 CareDx, Inc. Aktie
German listing (gettex) of CareDx, Inc. · home listing NASDAQ:CDNA
Follow CareDx, Inc. into a list and get an email when it puts out news.
Home listing price · NASDAQ:CDNA
$70.00 USD -4.44 (-6.0%)
Close on Nov 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:CDNA
- Day range
- $69.26 – $72.81 USDNov 20, 2026
- Volume
- 781,924 sharesNov 20, 2026
- Market cap
- $3.68B USDAt the close on Nov 20, 2026 · price × 52.54M shares outstanding
- 52-week range
- $15.56 – $90.87 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- $83.91M USDMedian day 1.18M shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:CDNA · Home | $70.00 USD | -4.44 (-6.0%) | 781,924 | $70.56 | $72.81 | $69.26 | $74.44 | Close on Nov 20, 2026 |
| Frankfurt:1K9 | €63.50 EUR | -4.50 (-6.6%) | — | €64.00 | €64.00 | €63.50 | €68.00 | Close on Nov 20, 2026 |
| Stuttgart:1K9 | €63.50 EUR | -2.00 (-3.1%) | — | €65.00 | €65.00 | €63.50 | €65.50 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:CDNA · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $70.00 | -4.44 | -6.0% | $70.56 | $72.81 | $69.26 | 781,924 | |
| $74.44 | -0.12 | -0.2% | $74.81 | $75.58 | $72.32 | 537,256 | |
| $74.56 | +0.84 | +1.1% | $74.30 | $75.53 | $72.03 | 813,950 | |
| $73.72 | -4.16 | -5.3% | $77.28 | $78.36 | $73.31 | 1,030,751 | |
| $77.88 | -1.93 | -2.4% | $78.51 | $80.00 | $76.67 | 714,737 | |
| $79.81 | -1.36 | -1.7% | $78.00 | $80.07 | $76.55 | 685,550 | |
| $81.17 | +0.40 | +0.5% | $82.00 | $84.10 | $80.18 | 770,847 | |
| $80.77 | -3.65 | -4.3% | $84.09 | $84.50 | $79.27 | 1,036,317 | |
| $84.42 | +5.86 | +7.5% | $80.80 | $85.74 | $80.00 | 1,093,687 | |
| $78.56 | +2.23 | +2.9% | $77.88 | $80.55 | $75.93 | 1,126,037 | |
| $76.33 | -9.53 | -11.1% | $83.60 | $83.60 | $75.81 | 2,056,061 | |
| $85.86 | -2.61 | -3.0% | $89.00 | $89.85 | $83.13 | 1,352,128 | |
| $88.47 | +2.59 | +3.0% | $85.63 | $90.05 | $85.44 | 1,585,957 | |
| $85.88 | -1.53 | -1.8% | $86.88 | $89.14 | $83.06 | 2,190,573 | |
| $87.41 | +15.89 | +22.2% | $82.10 | $90.87 | $81.22 | 3,552,531 | |
| $71.52 | -0.61 | -0.8% | $72.02 | $73.08 | $69.95 | 1,656,863 | |
| $72.13 | +1.60 | +2.3% | $69.91 | $73.43 | $69.00 | 905,915 | |
| $70.53 | +1.43 | +2.1% | $69.10 | $72.48 | $68.60 | 1,175,449 | |
| $69.10 | -0.11 | -0.2% | $68.87 | $70.31 | $68.33 | 602,691 | |
| $69.21 | +0.05 | +0.1% | $68.54 | $70.48 | $67.43 | 746,068 | |
| $69.16 | -1.58 | -2.2% | $69.65 | $71.51 | $66.84 | 917,916 | |
| $70.74 | +1.54 | +2.2% | $68.39 | $72.71 | $68.28 | 1,637,705 | |
| $69.20 | +2.12 | +3.2% | $67.20 | $70.81 | $65.89 | 1,561,966 | |
| $67.08 | +3.08 | +4.8% | $65.00 | $68.05 | $64.56 | 990,719 | |
| $64.00 | -2.675 | -4.0% | $66.34 | $68.09 | $62.85 | 1,497,600 | |
| $66.68 | +1.985 | +3.1% | $63.72 | $68.17 | $62.21 | 1,302,500 | |
| $64.69 | -0.74 | -1.1% | $64.40 | $67.73 | $63.34 | 1,191,400 | |
| $65.43 | +2.31 | +3.7% | $62.57 | $67.39 | $62.23 | 1,497,800 | |
| $63.12 | -0.55 | -0.9% | $63.28 | $64.47 | $61.34 | 900,000 | |
| $63.67 | +1.465 | +2.4% | $62.21 | $65.13 | $62.21 | 895,600 | |
| $62.21 | -0.835 | -1.3% | $61.89 | $63.45 | $61.19 | 1,571,200 | |
| $63.04 | -0.75 | -1.2% | $61.38 | $65.10 | $61.38 | 1,700,600 | |
| $63.79 | -6.06 | -8.7% | $70.89 | $72.51 | $63.74 | 2,561,100 | |
| $69.85 | +2.70 | +4.0% | $66.89 | $70.75 | $66.17 | 1,636,300 | |
| $67.15 | +0.92 | +1.4% | $66.33 | $69.80 | $65.88 | 1,588,100 | |
| $66.23 | +1.23 | +1.9% | $64.96 | $67.29 | $64.15 | 1,910,800 | |
| $65.00 | +0.98 | +1.5% | $63.87 | $65.63 | $63.12 | 1,768,100 | |
| $64.02 | -0.58 | -0.9% | $64.74 | $65.50 | $62.90 | 796,100 | |
| $64.60 | +0.92 | +1.4% | $62.30 | $65.50 | $62.30 | 1,081,400 | |
| $63.68 | +2.31 | +3.8% | $61.33 | $65.19 | $60.51 | 2,349,700 | |
| $61.37 | +7.06 | +13.0% | $55.29 | $63.09 | $54.52 | 2,499,900 | |
| $54.31 | -2.18 | -3.9% | $56.25 | $57.16 | $54.00 | 1,907,200 | |
| $56.49 | +2.16 | +4.0% | $54.44 | $56.85 | $53.78 | 1,966,100 | |
| $54.33 | +0.50 | +0.9% | $53.82 | $54.86 | $53.50 | 766,700 | |
| $53.83 | -0.45 | -0.8% | $53.97 | $54.46 | $53.12 | 1,384,000 | |
| $54.28 | +0.73 | +1.4% | $54.00 | $55.16 | $53.21 | 806,300 | |
| $53.55 | +0.91 | +1.7% | $52.61 | $54.49 | $52.61 | 846,100 | |
| $52.64 | +0.27 | +0.5% | $52.20 | $53.74 | $51.73 | 948,700 | |
| $52.37 | +2.11 | +4.2% | $50.49 | $52.67 | $50.17 | 795,200 | |
| $50.26 | +0.24 | +0.5% | $50.14 | $50.85 | $49.57 | 662,900 | |
| $50.02 | -0.01 | 0.0% | $49.19 | $51.69 | $48.64 | 1,606,700 | |
| $50.03 | -0.28 | -0.6% | $49.88 | $51.33 | $49.64 | 1,216,500 | |
| $50.31 | -0.57 | -1.1% | $50.50 | $50.87 | $49.46 | 935,100 | |
| $50.88 | +1.02 | +2.0% | $49.65 | $50.99 | $48.68 | 1,307,200 | |
| $49.86 | +0.26 | +0.5% | $49.75 | $50.50 | $48.39 | 636,700 | |
| $49.60 | +0.63 | +1.3% | $49.55 | $51.37 | $48.40 | 825,700 | |
| $48.97 | -1.14 | -2.3% | $49.93 | $50.62 | $48.25 | 1,247,800 | |
| $50.11 | +0.32 | +0.6% | $49.16 | $50.28 | $46.69 | 1,533,700 | |
| $49.79 | -2.57 | -4.9% | $51.50 | $52.38 | $49.60 | 1,178,100 | |
| $52.36 | +1.40 | +2.7% | $51.00 | $53.67 | $50.77 | 1,250,900 | |
| $50.96 | +0.16 | +0.3% | $50.15 | $51.08 | $49.07 | 1,415,300 | |
| $50.80 | +3.30 | +6.9% | $48.13 | $51.13 | $47.23 | 1,787,935 | |
| $47.50 | -1.11 | -2.3% | $48.30 | $48.51 | $46.92 | 769,594 | |
| $48.61 | +1.62 | +3.4% | $46.99 | $48.72 | $46.05 | 1,159,900 | |
| $46.99 | +0.48 | +1.0% | $45.90 | $47.85 | $45.33 | 911,200 |
- Ticker
- gettex:1K9
- Asset type
- Stock
- Sector
- Health care
- Industry
- Diagnostics & research services
- Exchange
- gettex
- Currency
- EUR
What changed lately
Latest news release · Nov 20, 2026
CareDx to Participate in Upcoming Investor Conferences
Latest earnings call · Oct 29, 2026
CareDx (NASDAQ:CDNA) Q3 2026 Earnings Call
Replay and transcript
Latest deck · Oct 29, 2026
Q3 2026 Earnings Presentation
Earnings · 28 slides
Latest news
CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Nov 6, 2026
Closed $84.42 (+7.5%) on Nov 9, 2026
CareDx Announces Third KOAR Analysis Published in Transplantation
Nov 3, 2026
Closed $88.47 (+3.0%) on Nov 3, 2026
CareDx Announces Third Quarter 2026 Financial Results
Oct 29, 2026
Closed $87.41 (+22.2%) on Oct 30, 2026
CareDx Announces New KOAR Data Linking Elevated AlloSure® Kidney to Nearly 3-Fold Higher Risk of Adverse Graft Outcomes in Patients with Borderline Rejection or TCMR at ASN Kidney Week 2026
Oct 22, 2026
Closed $69.16 (-2.2%) on Oct 22, 2026
CareDx to Report Third Quarter 2026 Financial Results on October 29, 2026
Oct 15, 2026
Closed $64.00 (-4.0%) on Oct 16, 2026
CareDx Announces Second Quarter 2026 Financial Results
Jul 30, 2026
Closed $38.10 (+7.6%) on Jul 30, 2026
CareDx to Report Second Quarter 2026 Financial Results on July 30, 2026
Jul 16, 2026
Closed $40.34 (+35.6%) on Jul 16, 2026
CareDx Announces Finalization of Solid Organ Transplant Molecular Testing Local Coverage Determination
Jul 16, 2026
Closed $40.34 (+35.6%) on Jul 16, 2026
CareDx Completes Acquisition of Naveris, Extending Leadership into High-Growth Specialty Oncology
Jul 1, 2026
Closed $29.19 (-0.2%) on Jul 2, 2026
CareDx, Inc. on 6ix
- Sector
- Health care
- Industry
- Diagnostics & research services
- News releases
- 32 in the last 12 months · 275 in all · newest Nov 20, 2026 · oldest 2019
- Calls
- 27 calls with a replay · 27 with a transcript · latest Oct 29, 2026
- Decks
- 25 decks · latest Oct 29, 2026
Where CareDx, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:CDNA · Home listing | NASDAQ | United States | USD |
| gettex:1K9 · This page | gettex | Germany | EUR |
| LS Exchange:A118WG | LS Exchange | Germany | EUR |
| Lang & Schwarz:A118WG | Lang & Schwarz | Germany | EUR |
| BOATS:CDNA | BOATS | United States | USD |
| Tradegate:1K9 | Tradegate | Germany | EUR |
| Dusseldorf:1K9 | Dusseldorf | Germany | EUR |
| Frankfurt:1K9 | Frankfurt | Germany | EUR |
| Munich:1K9 | Munich | Germany | EUR |
| Stuttgart:1K9 | Stuttgart | Germany | EUR |
Valuation
P/E 28.6× against a median of 24.0×: 5th lowest of 7 Diagnostics & research services companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026
- Enterprise value
- $3.43B USD
- P/E
- 28.6×
- EV/sales
- 6.9×
- EV/EBITDA
- No depreciation figure on 6ix yet
- Price/book
- 7.9×
- Gross margin
- Not reported
- Operating margin
- 23.4%
- Net margin
- 25.9%
- Debt to equity
- 0.0×
- Beta vs S&P 500
- 1.26
Diagnostics & research services: the 10 companies nearest in size, of 302 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| CareDx, Inc. · NASDAQ:CDNA | US$3.68B | US$3.43B | 28.6× | 6.9× | n/a | 7.9× | 25.9% | 0.0× | 1.26 |
| GRAIL, Inc. · NASDAQ:GRAL | US$4.46B | US$3.76B | n/a | 22.6× | n/a | 1.8× | −243.8% | 0.0× | 2.83 |
| SAI Life Sciences Ltd. · NSE:SAILIFE | US$4.13B | US$4.13B | 106× | 17.0× | 58.1× | 15.4× | 16.1% | 0.0× | n/a |
| BillionToOne, Inc. · NASDAQ:BLLN | US$3.83B | US$3.36B | 77.6× | 7.7× | 59.6× | 6.8× | 11.3% | 0.2× | 1.35 |
| Tecan Group AG · SIX:TECN | US$3.50B | US$3.49B | n/a | 3.3× | 34.0× | 2.6× | −12.5% | 0.2× | n/a |
| Piramal Pharma Limited · NSE:PPLPHARMA | US$3.42B | US$3.97B | n/a | 3.8× | 30.6× | 3.9× | −2.1% | 0.7× | n/a |
| Siegfried Holding AG · SIX:SFZN | US$3.40B | US$4.38B | 16.9× | 2.8× | 12.0× | 2.9× | 12.7% | 0.9× | n/a |
| Apeloa Pharmaceutical Co. Ltd. Class A · SZSE:000739 | US$3.29B | US$2.84B | 27.3× | 2.1× | n/a | 3.4× | 9.1% | 0.1× | n/a |
| Autobio Diagnostics Co., Ltd. Class A · SSE:603658 | US$3.28B | US$3.05B | 20.8× | 4.7× | n/a | 2.4× | 24.3% | 0.0× | n/a |
| Joinn Laboratories (China) Co., Ltd. Class A · SSE:603127 | US$3.04B | US$2.66B | 17.7× | 9.6× | n/a | 2.2× | 61.6% | 0.0× | n/a |
| MGI Tech Co., Ltd. Class A · SSE:688114 | US$2.92B | US$2.54B | n/a | 5.5× | n/a | 2.8× | −9.5% | 0.2× | n/a |
| Median of the others | US$3.41B | US$3.43B | 24.0× | 5.1× | 34.0× | 2.8× | 10.2% | 0.1× | 2.09 |
Forecasts
5 strong buy · 1 buy · 2 hold · Analysts' consensus from EODHD, read Nov 17, 2026. Not 6ix's view and not investment advice.
- Price target
- 94.43 USD · Analysts' mean
- EPS, year to Dec 2026
- 1.78 · 7 analysts
- Revenue, year to Dec 2026
- 524.8M · 8 analysts
Team and board
| Officer | Role |
|---|---|
| John W. Hanna | President and Chief Executive Officer |
| Keith Kennedy | Chief Financial Officer and Chief Operating Officer |
| Jeffrey A. Novack | General Counsel |
| Natasha Moshirian Wagner | Investor Relations |
| Jeffrey Teuteberg | Chief Medical Officer |
| Jessica Meng | Chief Commercial Officer |
| Jing Huang | Chief Data and AI Officer |
| Kashif Rathore | Chief Technology Officer |
| Marica Grskovic | Chief Strategy Officer |
| Robert N. Woodward | Chief Scientific Officer |
Events
Calls
| Call | When | Status |
|---|---|---|
| CareDx (NASDAQ:CDNA) Q3 2026 Earnings Call | Thu, Oct 29, 2026 · 4:30 PM ET | Replay |
| CareDx (NASDAQ:CDNA) Q2 2026 Earnings Call | Thu, Jul 30, 2026 · 4:30 PM ET | Replay |
| CareDx (NASDAQ:CDNA) Q1 2026 Earnings Call | Tue, Apr 28, 2026 · 4:30 PM ET | Replay |
| CareDx (NASDAQ:CDNA) Q4 2025 Earnings Call | Tue, Feb 24, 2026 · 4:30 PM ET | Replay |
| CareDx (NASDAQ:CDNA) Q3 2025 Earnings Call | Tue, Nov 04, 2025 · 4:30 PM ET | Replay |
| CareDx (NASDAQ:CDNA) Q2 2025 Earnings Call | Wed, Aug 06, 2025 · 4:30 PM ET | Replay |
| CareDx (NASDAQ:CDNA) Q1 2025 Earnings Call | Wed, Apr 30, 2025 · 4:30 PM ET | Replay |
| CareDx (NASDAQ:CDNA) Q4 2024 Earnings Call | Wed, Feb 26, 2025 · 4:30 PM ET | Replay |
| CareDx (NASDAQ:CDNA) Q3 2024 Earnings Call | Mon, Nov 04, 2024 · 4:30 PM ET | Replay |
| CareDx (NASDAQ:CDNA) Q2 2024 Earnings Call | Wed, Jul 31, 2024 · 4:30 PM ET | Replay |
All 27 calls
Results days
| Quarter | Results | Share move |
|---|---|---|
| Q3 2026 | Oct 29, 2026 · After close | +22.2% |
| Q2 2026 | Jul 30, 2026 · After close | +14.7% |
| Q1 2026 | Apr 28, 2026 · After close | −5.1% |
| Q4 2025 | Mar 4, 2026 | −0.3% |
| Q3 2025 | Nov 4, 2025 · After close | +13.8% |
| Q2 2025 | Aug 6, 2025 · After close | −7.9% |
| Q1 2025 | Apr 30, 2025 · After close | −10.7% |
| Q4 2024 | Feb 26, 2025 · After close | −0.2% |
| Q3 2024 | Nov 4, 2024 · After close | −0.1% |
| Q2 2024 | Jul 31, 2024 · After close | +18.0% |
All 20 quarters
| Quarter | Results | Share move |
|---|---|---|
| Q1 2024 | May 9, 2024 · After close | +34.1% |
| Q4 2023 | Feb 28, 2024 · After close | +9.5% |
| Q3 2023 | Nov 8, 2023 · After close | +13.9% |
| Q2 2023 | Aug 8, 2023 · After close | −11.2% |
| Q1 2023 | May 10, 2023 · After close | −2.7% |
| Q4 2022 | Feb 27, 2023 · After close | +14.3% |
| Q3 2022 | Nov 3, 2022 · After close | −14.5% |
| Q2 2022 | Aug 4, 2022 · After close | +8.6% |
| Q1 2022 | May 5, 2022 · After close | −18.6% |
| Q4 2021 | Feb 24, 2022 · After close | −1.9% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Q3 2026 Earnings Presentation | Earnings | 28 slides | Oct 29, 2026 |
| Q2 2026 Earnings Presentation | Earnings | 26 slides | Jul 30, 2026 |
| Q1 2026 Earnings Presentation | Earnings | 37 slides | Apr 28, 2026 |
| Q4 2025 Earnings Presentation | Earnings | 29 slides | Feb 24, 2026 |
| Investor Presentation (February 2026) | Investor deck | 35 slides | Feb 12, 2026 |
| Q3 2025 Earnings Presentation | Earnings | 24 slides | Nov 4, 2025 |
| Q2 2025 Earnings Presentation | Earnings | 31 slides | Aug 6, 2025 |
| Jefferies Global Healthcare Conference 2025 | Conference | 25 slides | Jun 5, 2025 |
| Q1 2025 Earnings Presentation | Earnings | 24 slides | Apr 30, 2025 |
| Q4 2024 Earnings Presentation | Earnings | 19 slides | Feb 26, 2025 |
All 25 decks
Financials
Annual, in USD
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 379.8M | 333.8M | 280.3M | 321.8M | 296.4M | 192.2M | 127.1M | 76.6M | 48.3M | 40.6M |
| Cost of revenue | 45.5M | 33.0M | 21.4M | 10.2M | ||||||
| Gross profit | 81.6M | 43.6M | 27.0M | 30.4M | ||||||
| Research and development | 71.4M | 72.5M | 82.4M | 90.4M | 76.5M | 48.9M | 30.7M | 14.5M | 12.4M | 12.4M |
| Operating income | -30.8M | 40.8M | -203.4M | -77.2M | -29.7M | -22.5M | -24.5M | -15.6M | -20.3M | -37.3M |
| Depreciation and amortization | 15.0M | 14.2M | 14.4M | 11.6M | 8.80M | 7.01M | 5.52M | 4.21M | 3.73M | 2.92M |
| EBITDA | -15.8M | 55.0M | -189.0M | -65.6M | -20.9M | -15.5M | -19.0M | -11.4M | -16.6M | -34.4M |
| Income before tax | -21.1M | 52.9M | -190.1M | -76.2M | -32.1M | -19.8M | -23.9M | -48.2M | -57.3M | -41.4M |
| Income tax | 271.0K | 310.0K | 141.0K | 379.0K | -1.43M | -1.04M | -1.98M | -1.43M | -1.71M | -1.61M |
| Net income | -21.4M | 52.5M | -190.3M | -76.6M | -30.7M | -18.7M | -22.0M | -46.8M | -55.5M | -39.5M |
| Earnings per share, basic | -0.40 | 1.00 | -3.54 | -1.44 | -0.59 | -0.40 | -0.52 | -1.31 | -2.38 | -2.39 |
| Earnings per share, diluted | -0.40 | 0.93 | -3.54 | -1.44 | -0.59 | -0.40 | -0.52 | -1.31 | -2.38 | -2.39 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 65.4M | 114.7M | 82.2M | 89.9M | 348.5M | 134.7M | 38.2M | 64.6M | 16.9M | 17.3M |
| Short-term investments | 111.8M | 146.0M | 153.2M | 203.2M | 0 | 90.0M | 0 | |||
| Receivables | 42.6M | 64.6M | 51.1M | 66.3M | 59.8M | 34.6M | 24.1M | 9.76M | 2.99M | 2.77M |
| Inventory | 26.7M | 19.5M | 19.5M | 19.2M | 17.2M | 10.0M | 6.01M | 4.94M | 5.53M | 5.46M |
| Current assets | 257.1M | 351.8M | 313.7M | 387.8M | 433.4M | 273.1M | 71.9M | 81.1M | 26.8M | 26.7M |
| Property, plant and equipment | 33.0M | 33.6M | 35.2M | 35.5M | 22.0M | 10.7M | 4.43M | 4.13M | 2.08M | 2.93M |
| Goodwill | 40.3M | 40.3M | 40.3M | 37.5M | 37.0M | 23.9M | 23.9M | 12.0M | 12.0M | 13.8M |
| Total assets | 413.2M | 491.1M | 466.8M | 543.0M | 566.6M | 368.5M | 151.7M | 130.7M | 83.6M | 76.7M |
| Accounts payable | 9.99M | 7.69M | 12.9M | 9.94M | 13.3M | 9.65M | 5.51M | 4.71M | 3.39M | 3.06M |
| Current liabilities | 89.8M | 89.4M | 78.1M | 76.0M | 77.3M | 69.2M | 34.8M | 19.5M | 42.9M | 40.8M |
| Long-term debt | 0 | 0 | 0 | 18.3M | 1.10M | |||||
| Total debt | 0 | 0 | 0 | 34.1M | 23.9M | |||||
| Total liabilities | 110.1M | 112.6M | 205.5M | 112.1M | 100.7M | 90.8M | 52.7M | 34.8M | 89.5M | 57.0M |
| Shareholders' equity | 303.1M | 378.4M | 261.3M | 430.9M | 465.9M | 277.7M | 99.0M | 95.9M | -6.13M | 19.5M |
| Shares outstanding | 50.9M | 54.8M | 51.5M | 53.5M | 52.9M | 49.4M | 42.5M | 41.4M | 28.8M | 21.3M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 42.0M | 38.0M | -18.4M | -25.2M | -19.3M | 33.4M | -2.77M | -4.01M | -14.3M | -16.5M |
| Capital spending | -2.04M | -186.0K | -549.0K | |||||||
| Free cash flow | -6.04M | -14.5M | -17.1M | |||||||
| Cash from investing | 2.16M | -483.0K | 40.4M | -228.5M | 47.7M | -100.4M | -22.6M | -7.93M | -6.11M | -21.1M |
| Cash from financing | -93.4M | -5.61M | -29.6M | -4.54M | 185.6M | 163.1M | -132.0K | 50.3M | 29.4M | 24.9M |
| Share buybacks | -87.8M | -522.0K | -27.5M | -642.0K | 0 | 0 | ||||
| Change in cash | -49.3M | 32.5M | -7.66M | -258.3M | 213.8M | 96.5M | -26.3M | 38.3M | 9.07M | -12.6M |
Filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 4 · Change in ownership | Nov 18, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Nov 16, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Nov 16, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Nov 16, 2026 | Other filings | SEC |
| 4 · Change in ownership | Nov 12, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Nov 12, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Nov 12, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Nov 10, 2026 | Other filings | SEC |
| SCHEDULE 13G · Big-stake notice | Nov 10, 2026 | Big-stake notice | SEC |
| 4 · Change in ownership | Nov 9, 2026 | Insider trade | SEC |
Show 200 filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 4 · Change in ownership | Nov 9, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Nov 5, 2026 | Other filings | SEC |
| 4 · Change in ownership | Nov 4, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Nov 3, 2026 | Insider trade | SEC |
| 10-Q · Quarterly report | Oct 29, 2026 | Quarterly report | SEC |
| 8-K · Current report | Oct 29, 2026 | Results | SEC |
| 4 · Change in ownership | Oct 5, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Oct 5, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Oct 5, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Oct 5, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Oct 5, 2026 | Insider trade | SEC |
| 8-K/A · Current report, amended | Sep 16, 2026 | Acquisition or disposal | SEC |
| 4 · Change in ownership | Sep 15, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Sep 15, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Aug 17, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Aug 14, 2026 | Other filings | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Aug 14, 2026 | Big-stake notice | SEC |
| 144 · Notice of proposed sale | Aug 13, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Aug 12, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Aug 11, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Aug 10, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Aug 10, 2026 | Other filings | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Aug 7, 2026 | Big-stake notice | SEC |
| 144 · Notice of proposed sale | Aug 7, 2026 | Other filings | SEC |
| SCHEDULE 13G · Big-stake notice | Aug 7, 2026 | Big-stake notice | SEC |
| 4 · Change in ownership | Aug 6, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 6, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 6, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 6, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Aug 5, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Aug 5, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Aug 5, 2026 | Other filings | SEC |
| 4 · Change in ownership | Aug 4, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Aug 4, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Aug 4, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Aug 4, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Aug 4, 2026 | Other filings | SEC |
| S-8 · Registration statement for employee plans | Jul 30, 2026 | Offer document | SEC |
| 10-Q · Quarterly report | Jul 30, 2026 | Quarterly report | SEC |
| 8-K · Current report | Jul 30, 2026 | Results | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Jul 27, 2026 | Big-stake notice | SEC |
| 4 · Change in ownership | Jul 17, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jul 17, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Jul 16, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Jul 16, 2026 | Other filings | SEC |
| 4 · Change in ownership | Jul 7, 2026 | Insider trade | SEC |
| 8-K · Current report | Jul 7, 2026 | Acquisition or disposal | SEC |
| 4 · Change in ownership | Jul 6, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jul 2, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jul 2, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jul 2, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 30, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Jun 29, 2026 | Other filings | SEC |
| 4 · Change in ownership | Jun 17, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 16, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 16, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 16, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 16, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 16, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 16, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 16, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 15, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Jun 15, 2026 | Other filings | SEC |
| 8-K · Current report | Jun 15, 2026 | Management or board change | SEC |
| 144 · Notice of proposed sale | Jun 11, 2026 | Other filings | SEC |
| 4 · Change in ownership | Jun 9, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 8, 2026 | Insider trade | SEC |
| DEFA14A · Additional proxy material | Jun 5, 2026 | Meeting notice | SEC |
| 144 · Notice of proposed sale | Jun 4, 2026 | Other filings | SEC |
| 4 · Change in ownership | May 18, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | May 15, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | May 14, 2026 | Other filings | SEC |
| 4 · Change in ownership | May 6, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | May 5, 2026 | Other filings | SEC |
| 4 · Change in ownership | May 4, 2026 | Insider trade | SEC |
| S-3ASR · Registration statement | Apr 28, 2026 | Offer document | SEC |
| 10-Q · Quarterly report | Apr 28, 2026 | Quarterly report | SEC |
| 8-K · Current report | Apr 28, 2026 | Results | SEC |
| ARS · Annual report to shareholders | Apr 27, 2026 | Annual report | SEC |
| DEFA14A · Additional proxy material | Apr 27, 2026 | Meeting notice | SEC |
| DEF 14A · Proxy statement | Apr 27, 2026 | Meeting notice | SEC |
| 8-K/A · Current report, amended | Apr 23, 2026 | Management or board change | SEC |
| 4 · Change in ownership | Apr 22, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Apr 20, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Apr 16, 2026 | Other filings | SEC |
| 4 · Change in ownership | Apr 16, 2026 | Insider trade | SEC |
| 8-K · Current report | Apr 16, 2026 | Results | SEC |
| 4 · Change in ownership | Apr 7, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Apr 3, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Apr 3, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Apr 3, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Apr 3, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Apr 3, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Apr 1, 2026 | Insider trade | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Mar 26, 2026 | Big-stake notice | SEC |
| 8-K/A · Current report, amended | Feb 25, 2026 | Results | SEC |
| 10-K · Annual report | Feb 25, 2026 | Annual report | SEC |
| 8-K · Current report | Feb 24, 2026 | Results | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Feb 12, 2026 | Big-stake notice | SEC |
| SCHEDULE 13G · Big-stake notice | Feb 9, 2026 | Big-stake notice | SEC |
| 4 · Change in ownership | Feb 4, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Feb 4, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Feb 4, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Feb 4, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Feb 4, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Feb 3, 2026 | Other filings | SEC |
| 4 · Change in ownership | Jan 23, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jan 20, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Jan 15, 2026 | Other filings | SEC |
| 8-K · Current report | Jan 12, 2026 | Results | SEC |
| 4 · Change in ownership | Jan 7, 2026 | Insider trade | SEC |
| 8-K · Current report | Dec 18, 2025 | Current report | SEC |
| 8-K · Current report | Dec 15, 2025 | Current report | SEC |
| 4 · Change in ownership | Dec 5, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Dec 4, 2025 | Other filings | SEC |
| SCHEDULE 13G · Big-stake notice | Nov 14, 2025 | Big-stake notice | SEC |
| 4 · Change in ownership | Nov 10, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Nov 7, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Nov 7, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Nov 5, 2025 | Other filings | SEC |
| S-8 · Registration statement for employee plans | Nov 4, 2025 | Offer document | SEC |
| 10-Q · Quarterly report | Nov 4, 2025 | Quarterly report | SEC |
| 8-K · Current report | Nov 4, 2025 | Results | SEC |
| 4 · Change in ownership | Nov 4, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Oct 31, 2025 | Other filings | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Oct 30, 2025 | Big-stake notice | SEC |
| 4 · Change in ownership | Oct 24, 2025 | Insider trade | SEC |
| 3 · Initial statement of ownership | Oct 24, 2025 | Insider trade | SEC |
| 8-K · Current report | Oct 24, 2025 | Management or board change | SEC |
| 4 · Change in ownership | Oct 7, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Sep 15, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Sep 15, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Sep 12, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Aug 11, 2025 | Insider trade | SEC |
| 3 · Initial statement of ownership | Aug 11, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Aug 7, 2025 | Insider trade | SEC |
| 10-Q · Quarterly report | Aug 6, 2025 | Quarterly report | SEC |
| 8-K · Current report | Aug 6, 2025 | Results | SEC |
| 4 · Change in ownership | Aug 5, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Aug 5, 2025 | Other filings | SEC |
| 4 · Change in ownership | Aug 5, 2025 | Insider trade | SEC |
| SCHEDULE 13G · Big-stake notice | Jul 24, 2025 | Big-stake notice | SEC |
| 4 · Change in ownership | Jul 14, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jul 10, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jul 8, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 23, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 20, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Jun 18, 2025 | Other filings | SEC |
| 4 · Change in ownership | Jun 17, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 17, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 17, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 17, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 17, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 17, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 17, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 17, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 13, 2025 | Insider trade | SEC |
| 8-K · Current report | Jun 12, 2025 | Management or board change | SEC |
| 144 · Notice of proposed sale | Jun 11, 2025 | Other filings | SEC |
| 4 · Change in ownership | Jun 10, 2025 | Insider trade | SEC |
| 8-K · Current report | Jun 3, 2025 | Current report | SEC |
| 4 · Change in ownership | May 30, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 29, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | May 28, 2025 | Other filings | SEC |
| 4 · Change in ownership | May 14, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | May 12, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | May 12, 2025 | Other filings | SEC |
| 4 · Change in ownership | May 8, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 7, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | May 6, 2025 | Other filings | SEC |
| 4 · Change in ownership | May 5, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 5, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | May 5, 2025 | Other filings | SEC |
| 4 · Change in ownership | May 2, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Apr 30, 2025 | Other filings | SEC |
| 10-Q · Quarterly report | Apr 30, 2025 | Quarterly report | SEC |
| 8-K · Current report | Apr 30, 2025 | Results | SEC |
| ARS · Annual report to shareholders | Apr 25, 2025 | Annual report | SEC |
| DEFA14A · Additional proxy material | Apr 25, 2025 | Meeting notice | SEC |
| DEF 14A · Proxy statement | Apr 25, 2025 | Meeting notice | SEC |
| 4 · Change in ownership | Apr 23, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Apr 17, 2025 | Insider trade | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Apr 17, 2025 | Big-stake notice | SEC |
| 4 · Change in ownership | Apr 9, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Apr 9, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Apr 8, 2025 | Insider trade | SEC |
| 8-K · Current report | Mar 28, 2025 | Management or board change | SEC |
| 4 · Change in ownership | Mar 25, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 25, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 25, 2025 | Insider trade | SEC |
This page holds 200 of 1,001 filings. Open Filings
Cap table
Built by 6ix from CareDx, Inc.’s releases · as of Nov 5, 2026
- Common shares
- 52,542,786
- Fully diluted
- 52,576,161
Fully diluted
| Line | Shares | As of |
|---|---|---|
| Common shares | 52,542,786 | Oct 26, 2026 |
| Options and RSUs | 33,375 | Nov 5, 2026 |
Warrants and options
| Lot |
|---|
| RSUs · expiry not stated |
Share count over time
| Count | Shares |
|---|---|
| Oct 26, 2026 | 52,542,786 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| George Bickerstaff Other companies: Sio Gene Therapies Inc (Director · Feb 11, 2018 – Apr 15, 2019 · Past); Innoviva, Inc. (Director · Dec 19, 2017 – Apr 25, 2022 · Past); Inovio Pharmaceuticals, Inc. (Director · Mar 21, 2017 – Mar 21, 2018 · Past); Ariad Pharmaceuticals Inc (Director · May 4, 2016 – Feb 16, 2017 · Past); BMP Sunstone CORP (Director · Apr 28, 2008 – Apr 28, 2008 · Past); Vion Pharmaceuticals Inc (Director · Jun 28, 2006 – Dec 11, 2008 · Past) | Director · Since at least Jul 16, 2014 |
| Brook H Byers Other companies: Veracyte, Inc. (Director · Oct 29, 2013 – May 20, 2014 · Past); Foundation Medicine Inc (Director · Sep 24, 2013 – Apr 7, 2015 · Past); Pacific Biosciences of California, Inc. (Director · Oct 26, 2010 – May 17, 2016 · Past); Genomic Health Inc (Director · May 25, 2006 – Apr 1, 2011 · Past) | Director · Jul 16, 2014 – Apr 1, 2016 · Past |
| Douglas S Miller Other companies: ChronoScale Corporation (Director · Since at least May 5, 2026); Applied Digital Corporation (Director · Since at least Apr 12, 2022); Procera Networks Inc (Director · May 30, 2013 – Jun 4, 2015 · Past); Telenav Inc (Director · May 12, 2010 – Feb 17, 2021 · Past) | Director · Jul 14, 2016 – Apr 1, 2017 · Past |
| Amy Abernethy Other companies: EQRx Inc (Director · Dec 17, 2021 – Nov 9, 2023 · Past); CM Life Sciences III Inc. (Director · Aug 2, 2021 – Aug 2, 2021 · Past); athenahealth Inc (Director · Oct 22, 2013 – Jun 6, 2018 · Past) | Director · Jul 1, 2018 – Jan 22, 2019 · Past |
| Charles Constanti Other companies: Procera Networks Inc (Chief Financial Officer · May 11, 2009 – Jun 4, 2015 · Past); Netopia Inc (VP, Chief Financial Officer · Jan 31, 2006 – Feb 6, 2007 · Past) | Chief Financial Officer · Apr 6, 2016 – Feb 17, 2017 · Past |
| Fred E Cohen Other companies: Intellia Therapeutics, Inc. (Director · Since at least Jun 9, 2026); Kyverna Therapeutics, Inc. (Director · Since at least May 27, 2026) | Director · Since at least Jun 12, 2026 |
| Hannah Valantine Other companies: BridgeBio Pharma, Inc. (Director · Since at least Oct 23, 2021); Pacific Biosciences of California, Inc. (Director · Since at least Jun 16, 2021) | Director · Since at least Jul 1, 2021 |
| Keith Kennedy Other companies: Veracyte, Inc. (COO / CFO · Dec 6, 2016 – Mar 2, 2021 · Past); MCG Capital Corp (President and CEO, Director · Aug 14, 2015 – Aug 18, 2015 · Past) | Chief Financial Officer and Chief Operating Officer · Since at least Sep 12, 2024 |
| Peter Maag Other companies: Kyverna Therapeutics, Inc. (Chief Executive Officer, Director · Feb 7, 2024 – Feb 7, 2024 · Past); Miromatrix Medical Inc (Director · Jun 23, 2021 – Dec 12, 2023 · Past) | Director · Since at least Jul 16, 2014 |
| Abhishek Jain Other companies: NeoGenomics, Inc. (Chief Financial Officer · Since at least Jan 12, 2026) | Chief Financial Officer · Since at least May 26, 2022 |
All 37 people
| Person | Seat |
|---|---|
| Christine M. Cournoyer Other companies: Spok Holdings, Inc. (Chair of the Board · Since at least Apr 1, 2025) | Director · Since at least May 6, 2025 |
| Grace E. Colón Other companies: Voyager Therapeutics, Inc. (Director · Since at least Jan 1, 2023) | Director · Jul 1, 2019 – Jun 16, 2023 · Past |
| Joshua DeFonzo Other companies: Lux Health Tech Acquisition Corp (Chief Executive Officer, Director · Oct 26, 2020 – Oct 26, 2020 · Past) | Chief Commercial Officer · Apr 1, 2015 – Jan 22, 2016 · Past |
| Michael Goldberg Other companies: Genomic Health Inc (Director · Jun 13, 2007 – Aug 23, 2007 · Past) | Director · Since at least Mar 31, 2026 |
| Reginald Seeto Other companies: Ardelyx, Inc. (Chief Operating Officer · Oct 22, 2016 – Jan 16, 2018 · Past) | See Remarks, Director · Nov 26, 2018 – Oct 2, 2023 · Past |
| Richard Bryan Riggsbee Other companies: Neogen Corporation (CFO · Since at least Aug 14, 2026) | Director · Since at least Jun 12, 2026 |
| Abraham Ronai | See Remarks · Sep 7, 2022 – Sep 20, 2023 · Past |
| Alexander L Johnson | See Remarks · Jul 19, 2021 – Aug 20, 2024 · Past |
| Arthur A Torres | Director · Since at least Sep 15, 2021 |
| Jeffrey A. Novack | General Counsel · Since at least Apr 24, 2024 |
| Jeffrey Teuteberg | Chief Medical Officer · Since at least Nov 3, 2026 |
| Jessica Meng | Chief Commercial Officer · Since at least Nov 4, 2024 |
| Jing Huang | Chief Data and AI Officer · Since at least Mar 5, 2026 |
| John Joseph Sninsky | Chief Scientific Officer · Jan 5, 2015 – Jan 29, 2018 · Past |
| John Walter Hanna Jr | President and CEO, Director · Since at least Apr 1, 2026 |
| John W. Hanna | President and Chief Executive Officer · Since at least Oct 5, 2026 |
| Kashif Rathore | Chief Technology Officer · Since at least Nov 5, 2026 |
| Marcel Konrad | See Remarks · Dec 31, 2020 – Dec 31, 2020 · Past |
| Marica Grskovic | Chief Strategy Officer · Since at least Dec 11, 2024 |
| Matthew J Meyer | Chief Business Officer · Jul 16, 2014 – Jan 22, 2016 · Past |
| Natasha Moshirian Wagner | Investor Relations · Since at least Jul 1, 2026 |
| Nathan Smith | Chief Financial Officer · Since at least Aug 7, 2025 |
| Robert N. Woodward | Chief Scientific Officer · Since at least Oct 23, 2025 |
| Sasha King | Chief Marketing Officer · Oct 20, 2017 – Aug 9, 2022 · Past |
| Suresh Gunasekaran | Director · Since at least Oct 22, 2025 |
| Todd Whitson | Chief Commercial Officer · Apr 18, 2016 – Feb 17, 2017 · Past |
| William A Hagstrom | Director · Since at least Jul 1, 2015 |
Log in to ask 6ix AI your own questions about CareDx, Inc.